efzofitimod
Generic: efzofitimod·Code: KRP-R120
efzofitimod: 1 clinical trial tracked.
efzofitimod evidence translation
What we can confirm
1 tracked trial
No verified listed company relationship
What it means
AI will separate confirmed drug evidence from unknown company context.
What to watch
Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected
Prepared research question
What is verified about efzofitimod, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence0 indications · 1 study sponsors
Related indications
No linked indication is available.
Study sponsors
Clinical Trial Registry Records (1)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients With Pulmonary Sarcoidosis
Primary endpoint: Change from baseline in mean daily oral corticosteroid (OCS) dose at Week 48
InterventionalRandomizedquadruple268 enrolledStarted 2022-09Completion 2025-0750 sites · Brazil, France, Germany, United StatesaTyr Pharma, Inc.